SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1207)1/21/2004 1:36:02 PM
From: Tomato  Read Replies (2) | Respond to of 1833
 
Don't think anyone picked KDUS as one of their entries in the biotech stock picking contest...maybe everyone figured it's not a biotech stock anymore?



To: scaram(o)uche who wrote (1207)1/22/2004 1:00:51 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 1833
 
>> SQNM revisits $4 <<

Every $0.50 in appreciation at SQNM will approximately cover legal/patent expenses at KDUS for a year. No? At $4.20, the value of the SQNM shares is now 9.5% of the KDUS market cap.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News